Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALB | P02768 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20806101 | 1.00 | TAS1R3 (0.37) | TAS1R3TAS1R1ABL1RIN1ADORA1 | |
| SCHEMBL20026293 | 0.85 | P2RY12 (0.43) | — | |
| SCHEMBL22524035 | 0.77 | YTHDC1 (0.50) | ADORA1 | |
| SCHEMBL20353076 | 0.77 | P2RY12 (0.45) | ABL1RIN1 | |
| SCHEMBL22524082 | 0.77 | ADORA3 (0.47) | TAS1R3TAS1R1ADORA1 | |
| SCHEMBL19145868 | 0.76 | P2RY12 (0.40) | ABL1RIN1 | |
| SCHEMBL19146392 | 0.75 | P2RY12 (0.42) | ABL1RIN1 | |
| SCHEMBL22336945 | 0.75 | KDM4E (0.51) | TAS1R3TAS1R1ALDH1A1LMNAALB | |
| SCHEMBL24444139 | 0.74 | ADORA1 (0.43) | ADORA1 | |
| SCHEMBL20324865 | 0.74 | P2RY1 (0.59) | TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019051489-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | SPEROVIE BIOSCIENCES, INC. (US) | 2019-03-14 | — | — | WO | disclosed |